Cargando…
Desferrioxamine decreases NAD redox potential of intact red blood cells: evidence for desferrioxamine as an inducer of oxidant stress in red blood cells
BACKGROUND: Desferrioxamine (DFO) is an important iron chelating agent. It has also been thought of as an agent with anti-oxidant potential as it chelates ferric iron in various parts of the body. However, there is evidence suggesting that it may paradoxically affect red blood cells (RBC) by inducin...
Autores principales: | Niihara, Yutaka, Ge, Junli, Shalev, Oded, Wu, Huiyuan, Tu, Amy, Tanaka, Kouichi R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC134457/ https://www.ncbi.nlm.nih.gov/pubmed/12398791 http://dx.doi.org/10.1186/1472-6904-2-8 |
Ejemplares similares
-
Desferrioxamine Reduces Oxidative Stress in the Lung Contusion
por: Basaran, Umit Nusret, et al.
Publicado: (2013) -
Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011) -
Desferrioxamine-related ocular toxicity: A case report
por: Simon, Sumu, et al.
Publicado: (2012) -
Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine
por: Savastano, Matteo, et al.
Publicado: (2019) -
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)